1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Raltegravir
1.2.3 Elvitegravir Combination Drugs
1.2.4 Dolutegravir and Its Combination Drug
1.2.5 Bictegravir Combination Drug
1.2.6 Cabotegravir
1.2.7 Other
1.3 Market by Application
1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2017-2028)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Region
2.2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Region (2017-2022)
2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Region (2023-2028)
2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Dynamics
2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Trends
2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
2.3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
2.3.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue
3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2017-2022)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2017-2022)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
3.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio
3.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2021
3.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Area Served
3.6 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
3.7 Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.8 Mergers & Acquisitions, Expansion Plans 4 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Type
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2017-2022)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2023-2028) 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Application
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Application (2017-2022)
5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2017-2028)
6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
6.2.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2022)
6.2.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2023-2028)
6.2.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
6.3.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2022)
6.3.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2023-2028)
6.3.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
6.4.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2017-2022)
6.4.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2017-2028)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
7.2.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2022)
7.2.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2023-2028)
7.2.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
7.3.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2022)
7.3.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2023-2028)
7.3.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
7.4.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2017-2022)
7.4.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2017-2028)
8.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
8.2.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
8.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
8.3.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
8.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region
8.4.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2017-2028)
9.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
9.2.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2022)
9.2.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2023-2028)
9.2.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
9.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
9.3.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2022)
9.3.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2023-2028)
9.3.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
9.4 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
9.4.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2017-2022)
9.4.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2017-2028)
10.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
10.2.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2017-2028)
10.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
10.3.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2017-2028)
10.4 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
10.4.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Adcock Ingram Limited
11.1.1 Adcock Ingram Limited Company Details
11.1.2 Adcock Ingram Limited Business Overview
11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.1.5 Adcock Ingram Limited Recent Developments
11.2 Affine Formulations Limited
11.2.1 Affine Formulations Limited Company Details
11.2.2 Affine Formulations Limited Business Overview
11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.2.5 Affine Formulations Limited Recent Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.3.5 Aurobindo Pharma Recent Developments
11.4 Biocon Limited
11.4.1 Biocon Limited Company Details
11.4.2 Biocon Limited Business Overview
11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.4.5 Biocon Limited Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.6.5 Cipla Recent Developments
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Details
11.7.2 Emcure Pharmaceuticals Business Overview
11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.7.5 Emcure Pharmaceuticals Recent Developments
11.8 Flamingo Pharmaceuticals Limited
11.8.1 Flamingo Pharmaceuticals Limited Company Details
11.8.2 Flamingo Pharmaceuticals Limited Business Overview
11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.8.5 Flamingo Pharmaceuticals Limited Recent Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.9.5 Gilead Sciences Recent Developments
11.10 Hetero Drugs
11.10.1 Hetero Drugs Company Details
11.10.2 Hetero Drugs Business Overview
11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.10.5 Hetero Drugs Recent Developments
11.11 IPCA Laboratories
11.11.1 IPCA Laboratories Company Details
11.11.2 IPCA Laboratories Business Overview
11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.11.5 IPCA Laboratories Recent Developments
11.12 Janssen Pharmaceutica (Johnson & Johnson)
11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details
11.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview
11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Developments
11.13 LAURUS Labs
11.13.1 LAURUS Labs Company Details
11.13.2 LAURUS Labs Business Overview
11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.13.5 LAURUS Labs Recent Developments
11.14 Medisist Pharma
11.14.1 Medisist Pharma Company Details
11.14.2 Medisist Pharma Business Overview
11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.14.5 Medisist Pharma Recent Developments
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.15.5 Merck Recent Developments
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.16.5 Mylan Recent Developments
11.17 Ranbaxy Pharmaceuticals
11.17.1 Ranbaxy Pharmaceuticals Company Details
11.17.2 Ranbaxy Pharmaceuticals Business Overview
11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.17.5 Ranbaxy Pharmaceuticals Recent Developments
11.18 Shanghai Desano Pharmaceuticals
11.18.1 Shanghai Desano Pharmaceuticals Company Details
11.18.2 Shanghai Desano Pharmaceuticals Business Overview
11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.18.5 Shanghai Desano Pharmaceuticals Recent Developments
11.19 ViiV Healthcare (GSK)
11.19.1 ViiV Healthcare (GSK) Company Details
11.19.2 ViiV Healthcare (GSK) Business Overview
11.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.19.4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2017-2022)
11.19.5 ViiV Healthcare (GSK) Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
